Method for tumor perfusion assessment in clinical trials using dynamic contrast enhanced MRI

• US 20060025667A1
• Filed: 07/29/2004
• Published: 02/02/2006
• Est. Priority Date: 07/29/2004
• Status: Abandoned Application

• Current Assignee: VirtualScopics, LLC (Koninklijke Philips N.V.)
• Original Assignee: VirtualScopics, LLC (Koninklijke Philips N.V.)
• Inventors: Ashton, Edward
• Application Number:
  US10/901,160
• Publication Number:
  US 20060025667A1
• Time in Patent Office: Days
• US Class Current: 600/407
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

Abstract

In a clinical trial using dceMRI, the assessment of tumor perfusion has problems of noise and reproducibility. To address those problems, an end-to-end method develops and enforces a standard imaging protocol, ensures site compliance both by pre-qualification and throughout the trial, ensures that the scanners function properly both at the outset and throughout the trial, develops an analysis process with automation and quality control to prevent human error, and provides analysis software to perform the assessment and to provide an electronic audit trail.

Claims

1. A method for providing reproducible measurements of parameters relating to vascularity of a tumor in a patient during a clinical trial and for reducing or eliminating effects of noise on the measurements of the parameters, the method comprising:

(a) developing a standard imaging protocol for use at a plurality of sites, each of the plurality of sites having at least one scanner on which the imaging protocol is to be implemented;

(b) ensuring that each of the plurality of sites complies with the standard imaging protocol;

(c) ensuring that the at least one scanner at each of the plurality of sites is operating correctly;

(d) developing an automated process for analyzing image data taken from the tumor to provide the reproducible measurements;

(e) taking the image data from the tumor using a scanner at one of the plurality of sites; and

(f) determining the reproducible measurements from the image data in step (e), using the automated process of step (d).

2. The method of claim 1, wherein step (e) is performed through dynamic contrast enhanced magnetic resonance imaging.

3. The method of claim 2, wherein the standard imaging protocol of step (a) specifies at least one of the following:

the patient'"'"'s breathing, a dose and rate of contrast injection into the patient, and an optimization of one of coverage, signal-to-noise ratio, and temporal resolution.

4. The method of claim 3, wherein step (b) comprises face-to-face training of participating technicians at each of the plurality of sites in the standard imaging protocol.

5. The method of claim 2, wherein step (b) comprises:

(i) pre-qualifying each of the plurality of sites to determine whether each of the plurality of sites is capable of implementing the standard imaging protocol;

(ii) face-to-face training of participating technicians at each of the plurality of sites in the standard imaging protocol; and

(iii) providing feedback to each of the plurality of sites on compliance with the standard imaging protocol and quality of image data.

6. The method of claim 5, wherein step (b)(iii) is performed a plurality of times for each of the plurality of sites throughout the clinical trial.

7. The method of claim 2, wherein step (c) comprises:

(i) providing at least one phantom;

(ii) imaging the at least one phantom in the at least one scanner at each of the plurality of sites;

(iii) determining, from step (c)(ii), whether each scanner is finctioning correctly; and

(iv) performing maintenance on any scanner which is determined in step (c)(iii) not to be functioning correctly.

8. The method of claim 7, wherein steps (c)(ii) through (c)(iv) are performed during step (b).

9. The method of claim 8, wherein steps (c)(ii) through (c)(iv) are also performed a plurality of additional times throughout the clinical trial.

10. The method of claim 2, wherein step (d) comprises developing software for analyzing the image data.

11. The method of claim 10, wherein the software comprises software for performing a script-driven analysis.

12. The method of claim 11, wherein the script-driven analysis comprises volumetric analysis and perfusion analysis.

13. The method of claim 12, wherein the software further comprises software for performing automated warp-based registration to align time points in the image data and for performing semi-automated tumor margin identification through geometrically constrained region growth.

14. The method of claim 10, wherein the software comprises software for automatically identifying an arterial input function relating to the tumor.

15. The method of claim 14, wherein the software further comprises software for performing an automated calculation of the parameters.

16. The method of claim 15, wherein the automated calculation of the parameters is performed using a Tofts model.

17. The method of claim 15, wherein the automated calculation of the parameters is performed using a Lee model.

18. The method of claim 10, wherein the software comprises software for producing an electronic audit trail.